neuroCare and Kyowa sign an equity participation paving the way for a strategic joint venture in Japan neuroCare Group GmbH (“neuroCare”) personalizes mental health therapy following a detailed assessment and achieves world best clinical outcomes employing its scientifically proven protocols. neuroCare’s assessment analyses sleep/circadian rhythm as much as psycho-diagnostic, genetic and other biomarkers empowering clinicians… Read More »
Depression is a common but serious illness. Transcranial Magnetic Stimulation (TMS) Therapy is a proven and safe, drug-free treatment for individuals suffering from depression.
Attention deficit hyperactivity disorder (ADHD) is a common behavioral disorder among children, adolescents, and can persist into adulthood. Neurofeedback, as provided by our professionals, is a safe and effective, drug-free treatment option for individuals struggling with ADHD.
The neuroCare Difference
neuroCare Centers of America is part of an international network of centers of excellence dedicated to helping patients suffering from neuropsychiatric illnesses that have not been helped by traditional medication management.
Long Island NeuroCare Therapy provides state-of-the-art depression and ADHD care for patients not helped by, intolerant of or contraindicated for psychotropic medications through the use of neuromodulation techniques. Neuromodulation utilizes advanced technology to leverage the brain’s natural ability to build new or improve the function of networks that control mood and behavior. We employ personalized care through a thorough initial assessment followed by the use of a scientifically proven neuromodulation treatment protocols selected for each patient. These protocols are implemented to help patients get truly well, not just to gain a reduction in their symptoms.
If you are a mental healthcare or other professional healthcare provider and would like to learn more about Long Island NeuroCare Therapy and the innovative services we provide, please contact Frank Scolaro.